Cost effectiveness and resource allocation : C/E
Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review.
Mojtaba Jafari, Parisa Mehdizadeh, Ehsan Teymourzadeh, Mahmood Salesi, Khosro Keshavarz, Mohammad Ali Abyazi, Mohammad Heiat, Seyed Moayed Alavian
Published: 202510.1186/s12962-025-00700-1
No abstract available for this study.